Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1451-1475 of 2409. (97 Page(s) Totally) << < 54 55 56 57 58 59 60 61 62 63 > >> View [10|25|50] records per page

Date	Title	Relation
2013-05	Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization	Biotechnology Advances. 2013 May;31(3):396-401.
2013-05	Activation of PPAR-alpha induces cell cycle arrest and inhibits transforming growth factor-beta1 induction of smooth muscle cell phenotype in 10T1/2 mesenchymal cells	Cellular Signalling. 2013 May;25(5):1252-1263.
2013-05	Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase	Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2013 May;1833(5):1147-1156.
2013-05	Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo	Oncology Letters. 2013 May;5(5):1567-1571.
2013-05	Mefloquine exerts anticancer activity in prostate cancer cells via ROS-mediated modulation of Akt, ERK, JNK and AMPK signaling	Oncology Letters. 2013 May;5(5):1541-1545.
2013-05	Tumor burden talks in cancer treatment with PEGylated liposomal drugs	PLoS ONE. 2013 May;8(5):Article number e63078.
2013-05	Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma	Biomarkers and Genomic Medicine. 2013 May;5(1-2):31-38.
2013-05	E2F transcription factor 1 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinomas	Biomarkers and Genomic Medicine. 2013 May;5(1-2):23-30.
2013-05	Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 10619.
2013-05	Effective treatment of aggressive B-cell lymphomas by downregulated NIK-induced noncanonical NF-kappa B pathway activation through inhibition of BAFF	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e13554.
2013-05	KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018.
2013-05	Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032.
2013-04-24	Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling	International Journal of Molecular Sciences. 2013 Apr 24;14(5):8801-8817.
2013-04-22	The epidemiology of neuroendocrine tumors in Taiwan: A nation-wide cancer registry-based study	PLoS ONE. 2013 Apr 22;8(4):Article number e62487.
2013-04	Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma	Tumor Biology. 2013 Apr;34(2):759-768.
2013-04	Up-regulation of miR-182 by Beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK	Biochimica et Biophysica Acta (BBA)-General Subjects. 2013 Apr;1830(4):3067-3076.
2013-04	SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential	Tumor Biology. 2013 Apr;34(2):1107-1117.
2013-04	Functional implication of TGFBR3 dysregulation and its clinical application in oral cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 3987.
2013-04	Generation and characterization of highly selective cathepsin S inhibitors with potentials against pancreatic cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 5562.
2013-04	3-D imaging and illustration of nerve-lesion association in the mouse tongue of experimental oral cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 716
2013-04	EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
2013-04	Autophagy induced by cathepsin S inhibition causes early ROS production for oxidative DNA damage and subsequent cell death	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 1661.
2013-04	Serum retinol and risk of head and neck cancer	Cancer Research. 2013 Apr;73(8):Abstract number 105.
2013-03-29	Secreted heat shock protein 90alpha (HSP90alpha) induces nuclear factor-kappaB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion	Journal of Biological Chemistry. 2013 Mar 29;288(13):9001-9010.
2013-03-15	Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from antrodia camphorata on the inflammatory mediator expression in mice	Journal of Agricultural and Food Chemistry. 2013 Mar 15;61(21):5064-5071.

Showing items 1451-1475 of 2409. (97 Page(s) Totally) << < 54 55 56 57 58 59 60 61 62 63 > >> View [10|25|50] records per page